Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team.

C Bassi, C Procacci, G Zamboni, A Scarpa, G Cavallini, P Pederzoli
{"title":"Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team.","authors":"C Bassi,&nbsp;C Procacci,&nbsp;G Zamboni,&nbsp;A Scarpa,&nbsp;G Cavallini,&nbsp;P Pederzoli","doi":"10.1385/ijgc:27:3:181","DOIUrl":null,"url":null,"abstract":"<p><strong>Methods: </strong>Literature is thoroughly reviewed and compared to our own experience.</p><p><strong>Results: </strong>Clinical history data do not appear to be useful in differentiating between benign and malignant cases. Usually IPMT patients are older than individuals suffering from chronic obstructive pancreatitis and tend to drink and smoke less. Malignant forms of IPMT are more frequently associated with diabetes, and pain seems to be more frequent in benign cases, although these findings are not confirmed in all reports. Also, laboratory tests are of little use, whereas imaging findings currently enable us to reach a correct diagnosis in about 70% of cases without differentiating in a reliable and definitive way the benign or malignant nature of the neoplasm. The WHO classification appears to be related to the different prognosis. Surgery, whenever possible, is the gold standard treatment.</p><p><strong>Conclusion: </strong>IPMT are a recent established clinical entity embracing a spectrum of lesions ranging from benign to malignant infiltrating cases. The only recognized radical treatment is surgery. Despite diagnostic capacity based on clinical presentation and imaging techniques has becoming increasingly refined we are still incapable of identifying the different degree of malignancy preoperatively, if any. The lengthy mean survival after resection confirm the high potential cure rate of IPMT of the pancreas.</p>","PeriodicalId":73464,"journal":{"name":"International journal of pancreatology : official journal of the International Association of Pancreatology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2000-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1385/ijgc:27:3:181","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pancreatology : official journal of the International Association of Pancreatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1385/ijgc:27:3:181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

Methods: Literature is thoroughly reviewed and compared to our own experience.

Results: Clinical history data do not appear to be useful in differentiating between benign and malignant cases. Usually IPMT patients are older than individuals suffering from chronic obstructive pancreatitis and tend to drink and smoke less. Malignant forms of IPMT are more frequently associated with diabetes, and pain seems to be more frequent in benign cases, although these findings are not confirmed in all reports. Also, laboratory tests are of little use, whereas imaging findings currently enable us to reach a correct diagnosis in about 70% of cases without differentiating in a reliable and definitive way the benign or malignant nature of the neoplasm. The WHO classification appears to be related to the different prognosis. Surgery, whenever possible, is the gold standard treatment.

Conclusion: IPMT are a recent established clinical entity embracing a spectrum of lesions ranging from benign to malignant infiltrating cases. The only recognized radical treatment is surgery. Despite diagnostic capacity based on clinical presentation and imaging techniques has becoming increasingly refined we are still incapable of identifying the different degree of malignancy preoperatively, if any. The lengthy mean survival after resection confirm the high potential cure rate of IPMT of the pancreas.

胰腺导管内乳头状粘液瘤。维罗纳大学胰腺小组。
方法:全面查阅文献,并与自身经验进行比较。结果:临床病史资料在良、恶性病例的鉴别中似乎没有用处。通常IPMT患者比慢性阻塞性胰腺炎患者年龄更大,并且往往饮酒和吸烟更少。恶性IPMT更常与糖尿病相关,而疼痛似乎在良性病例中更常见,尽管这些发现并未在所有报告中得到证实。此外,实验室检查几乎没有用处,而目前影像学检查使我们能够在大约70%的病例中得到正确的诊断,而不能以可靠和明确的方式区分肿瘤的良性或恶性性质。世界卫生组织的分类似乎与不同的预后有关。手术,只要可能,是金标准的治疗方法。结论:IPMT是最近建立的一种临床实体,包括从良性到恶性浸润的一系列病变。唯一公认的根治性治疗是手术。尽管基于临床表现和成像技术的诊断能力日益完善,但我们仍然无法在手术前识别不同程度的恶性肿瘤,如果有的话。切除后较长的平均生存期证实了胰腺IPMT的高潜在治愈率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信